Novel therapeutic targets
New therapies based on targeting intrinsically disordered proteins (IDPs).
Unmet medical needs
Focused on cancer diseases. Multiple myeloma is one of our priorities.
Tailor-made technologies
In house strategies to discover and to design drugs directed to IDPs.